BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Head and neck cancer AND EGFR, mENA, 1956, ENSG00000146648, P00533, ERBB1, ERBB
4249 results:

  • 1. Protective effect of magnesium preloading on cisplatin-induced nephrotoxicity: which dose is more suitable?
    Ilhan Y; Onder AH; Ozbay MF; Karakaya G; Sezgin Goksu S; Ozturk B; Coskun HS
    Eur Rev Med Pharmacol Sci; 2024 May; 28(9):3403-3413. PubMed ID: 38766796
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Erythema dyschromicum perstans-like eruptions induced by epidermal growth factor receptor inhibitors in patients with lung cancer.
    Bang AS; Said JT; Hirner J; Rana J; Pugliese S; Wang JY; Zaba L; Zhao L; Doan L; Smith J; Kwong BY
    Support Care Cancer; 2024 May; 32(6):354. PubMed ID: 38750379
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Novel therapeutic strategies for rare mutations in non-small cell lung cancer.
    Gou Q; Gou Q; Gan X; Xie Y
    Sci Rep; 2024 May; 14(1):10317. PubMed ID: 38705930
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Intratumoral therapies in head and neck squamous cell carcinoma: A systematic review and future perspectives.
    Jiménez-Labaig P; Rullan A; Braña I; Hernando-Calvo A; Moreno V; Doger B; Bitar G; Ap Dafydd D; Melcher A; Harrington KJ
    Cancer Treat Rev; 2024 Jun; 127():102746. PubMed ID: 38696902
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. The involvement of epidermal growth factor receptor/protein kinase B signaling in the tumor intrinsic PD-L1-induced malignant potential of oral squamous cell carcinoma.
    Sasabe E; Tomomura A; Yamamoto T
    J Oral Pathol Med; 2024 May; 53(5):310-320. PubMed ID: 38693616
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Dexrazoxane inhibits the growth of esophageal squamous cell carcinoma by attenuating SDCBP/MDA-9/syntenin-mediated egfr-PI3K-Akt pathway activation.
    Du R; Xiao N; Han L; Guo K; Li K; Chen Z; Zhang H; Zhou Z; Huang Y; Zhao X; Bian H
    Sci Rep; 2024 Apr; 14(1):9167. PubMed ID: 38649770
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Decabromodiphenyl ether exposure reduces dabrafenib sensitivity of papillary thyroid carcinoma harboring BRAF
    Wang X; Cui X; Wang Y; Wang Q; Sun F; Liu Z
    Toxicology; 2024 May; 504():153807. PubMed ID: 38641160
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Near-infrared imaging of head and neck squamous cell carcinoma using indocyanine green that targets the
    Yuan Y; Fan T; Wang J; Yuan Y; Tao X
    J Biomed Opt; 2024 Apr; 29(4):046002. PubMed ID: 38633382
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. The application of different machine learning models based on PET/CT images and egfr in predicting brain metastasis of adenocarcinoma of the lung.
    Kong C; Yin X; Zou J; Ma C; Liu K
    BMC Cancer; 2024 Apr; 24(1):454. PubMed ID: 38605303
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Evaluation of Some Prognostic Biomarkers in Human Papillomavirus-Related Multiphenotypic Sinonasal Carcinoma.
    Alabiad MA; Said WMM; Adim AMA; Alorini M; Shalaby AM; Samy W; Elshorbagy S; Mandour D; Saber IM; Yahia AIO; Khairy DA
    Iran J Med Sci; 2024 Mar; 49(3):156-166. PubMed ID: 38584650
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. New Treatment Options for Patients With Oncogene-Addicted Non-Small Cell Lung cancer Focusing on
    Saw SPL; Le X; Hendriks LEL; Remon J
    Am Soc Clin Oncol Educ Book; 2024 Apr; 44(3):e432516. PubMed ID: 38560815
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. FUT8-mediated aberrant N-glycosylation of SEMA7A promotes head and neck squamous cell carcinoma progression.
    Liu Z; Meng X; Zhang Y; Sun J; Tang X; Zhang Z; Liu L; He Y
    Int J Oral Sci; 2024 Mar; 16(1):26. PubMed ID: 38548747
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Microbiome Dysbiosis Is Associated with Castration Resistance and cancer Stemness in Metastatic Prostate cancer.
    Uzelac M; Xin R; Ongkeko WM
    Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542265
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Near-Infrared Photoimmunotherapy Using a Protein Mimetic for egfr-Positive Salivary Gland cancer.
    Yamaguchi H; Suzuki T; Okada Y; Ono J; Sano H; Banba A; Sakata H; Ishikawa A; Morita T
    Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542206
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Palbociclib inhibits the progression of head and neck cancer and improves the Cetuximab response under specific condition in vitro and in vivo.
    Li R; Wang Q; Zhao Y; Zhu Y; Wang X
    Mol Biol Rep; 2024 Mar; 51(1):455. PubMed ID: 38536540
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Synthesis and biological evaluation of 1-phenyl-tetrahydro-β-carboline-based first dual PRMT5/egfr inhibitors as potential anticancer agents.
    Zhang J; Liu X; Sa N; Zhang JH; Cai YS; Wang KM; Xu W; Jiang CS; Zhu KK
    Eur J Med Chem; 2024 Apr; 269():116341. PubMed ID: 38518523
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. egfr overexpression and macrophage infiltration correlate with poorer prognosis in HPV-negative oropharyngeal cancer via STAT6 signaling.
    Lee HP; Li CJ; Lee CC
    Head Neck; 2024 Jun; 46(6):1294-1303. PubMed ID: 38497289
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. [History and Perspective of Chemotherapy in Advanced Esophageal cancer].
    Shiraishi K; Kato K
    Gan To Kagaku Ryoho; 2024 Mar; 51(3):240-244. PubMed ID: 38494800
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. The antitumor effects of herbal medicine Triphala on oral cancer by inactivating PI3K/Akt signaling pathway: based on the network pharmacology, molecular docking, in vitro and in vivo experimental validation.
    Hu S; Li S; Xu Y; Huang X; Mai Z; Chen Y; Xiao H; Ning W; Gaus S; Savkovic V; Lethaus B; Zimmerer R; Acharya A; Ziebolz D; Schmalz G; Huang S; Zhao J; Hu X
    Phytomedicine; 2024 Jun; 128():155488. PubMed ID: 38493718
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. In vitro antimetastatic potential of pseudolaric acid B in HSC-3 human tongue squamous carcinoma cell line.
    Yu HJ; Kim JH; Choi SJ; Cho SD
    Arch Oral Biol; 2024 Jun; 162():105940. PubMed ID: 38479277
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 213.